Scrip is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


RxKinetix Inc.

Division of Endo International PLC

Latest From RxKinetix Inc.

RxKinetix Inc.

RxKinetix is developing two polymer-based sustained release delivery systems. {Micronix} permits water soluble drugs, including proteins, peptides and oligonucleotides, to be blended with polymers in microparticles 1-5 microns in diameter. {ProGelz} achieves site-specific sustained release of macromolecules.


Drug Delivery Start-ups

Knowing that the competition's tougher, the new crop of drug delivery companies grows increasingly specialized.

See All

Company Information

  • Industry
  • Pharmaceuticals
    • Drug Delivery
      • Controlled Release
      • Macromolecule
      • Pulmonary
      • Site Specific
      • Topical Delivery
    • Vaccines
  • Therapeutic Areas
  • Cancer
  • Infectious & Viral Diseases
  • Neurology, Nervous System
  • Alias(es)
  • Ownership
  • Private
  • Headquarters
  • Worldwide
    • North America
      • USA
  • Parent & Subsidiaries
  • Endo International PLC
  • Senior Management
  • John E Lucas, Pres. & CEO
    Rana S Gill, Treas. & CFO
    Kenneth R Lynn, SVP, Corp. Dev.
    Gary J Rosenthal, PhD, VP, Drug Dev.
  • Contact Info
  • RxKinetix Inc.
    Phone: (303) 926-1900
    3122 Sterling Circle
    3122 Sterling C
    Boulder, CO 80301